Author: Zeouk, Ikrame; Bekhti, Khadija; Lorenzo-Morales, Jacob
Title: From Wuhan to COVID-19 Pandemic: An Up-to-Date Review of Its Pathogenesis, Potential Therapeutics, and Recent Advances Cord-id: dv60ayn0 Document date: 2020_6_4
ID: dv60ayn0
Snippet: The emergence of a novel human coronavirus (SARS-CoV-2) causing severe contagious respiratory tract infections presents a serious threat to public health worldwide. To date, there are no specific antiviral agents available for this disease, currently known as COVID-19. Therefore, genomic sequencing and therapeutic clinical trials are being conducted to develop effective antiviral agents. Several reports have investigated FDA-approved drugs as well as in silico virtual screening approaches such a
Document: The emergence of a novel human coronavirus (SARS-CoV-2) causing severe contagious respiratory tract infections presents a serious threat to public health worldwide. To date, there are no specific antiviral agents available for this disease, currently known as COVID-19. Therefore, genomic sequencing and therapeutic clinical trials are being conducted to develop effective antiviral agents. Several reports have investigated FDA-approved drugs as well as in silico virtual screening approaches such as molecular docking and modeling to find novel antiviral agents. Until now, antiparasitic drugs such as chloroquine have shown the most relevant results. Furthermore, there is an urgent need to understand the pathogenesis of this novel coronavirus, its transmission routes, surface survival and evolution in the environment. So far, the scientific community has indicated a possible transmission of COVID-19 via blood transfusion which is challenging in the case of asymptomatic individuals. Protocols for pathogen inactivation are also needed. In this paper, we reviewed recent findings about this life-threatening pandemic.
Search related documents:
Co phrase search for related documents- abdominal discomfort vomiting and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8
- abdominal discomfort vomiting nausea and acute respiratory syndrome: 1, 2, 3, 4, 5, 6
- abdominal discomfort vomiting nausea diarrhea and acute respiratory syndrome: 1, 2, 3, 4
- accessory protein and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- action possible mechanism and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- active protection and acute respiratory syndrome: 1, 2, 3
- active surveillance and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- active surveillance and local control: 1, 2, 3, 4
- acute respiratory syndrome and addition experiment: 1, 2
- acute respiratory syndrome and addition experiment time: 1
- acute respiratory syndrome and adenosine analogue: 1, 2, 3, 4
- acute respiratory syndrome and administrative decision: 1
- acute respiratory syndrome and local control: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and lock contact: 1, 2
Co phrase search for related documents, hyperlinks ordered by date